Ignite Creation Date:
2024-05-05 @ 12:06 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00242099
Status:
COMPLETED
Last Update Posted:
2008-04-16
First Post:
2005-10-18
Brief Title:
Clinical Utility of Monitoring for Human Herpesvirus-6 HHV-6 and Human Herpesvirus-7 HHV-7 After Liver Transplant
Sponsor:
University Health Network Toronto
Organization:
University Health Network Toronto
Study Overview
Official Title:
The Clinical Utility of Monitoring for Human Herpesvirus-6 HHV-6 and Human Herpesvirus-7 HHV-7 After Liver Transplant A Randomized Trial
Status:
COMPLETED
Status Verified Date:
2005-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Human herpesvirus-6 HHV-6 and -7 HHV-7 infections are common after transplantation Such infections may predispose transplant patients to other infections contribute to a recurrence of hepatitis C virus and affect rejection and function of the transplanted liver Given the significant clinical impact of these viruses routine laboratory monitoring may be beneficial by identifying patients who have persistent or high levels of infection In these patients immunosuppressive medications could be adjusted or antiviral medications administered There are currently no randomized trials that address this important question This prospective randomized trial will analyze whether routine laboratory monitoring for HHV-6 and -7 is clinically useful and whether it would improve overall outcomes in transplant recipients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| PSI-04-53 | None | None | None |